Brickell Biotech Inc. (BBI) PT Lowered to $1 at Oppenheimer, But Analyst Reiterates Buy Rating on BBI-02 Potential
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell lowered the price target on Brickell Biotech Inc. (NASDAQ: BBI) to $1.00 (from $4.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
